$0.8700
-0.30-25.64%
Últ. Act.: Oct 29, 11:24 AM
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky...
Puedes comprar acciones de BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (OTCQB:BCLI) a través de cualquier corretaje en línea.
No hay competidores como tal para BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..
No existe ningún análisis de BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. que proporcione un precio objetivo de consenso.
El precio de las acciones de BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) es de 0.87 dólares, actualizado por última vez el 29 de octubre de 2026 a las 11:24 GMT-4.
No hay dividendos previstos para BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..
No hay informes de resultados previstos para BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..
No hay ninguna división de acciones prevista para BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..
BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. está en el sector Health Care y en la industria Biotechnology. Cotiza en el OTCQB.
Brainstorm Cell Therapeutics Inc is a biotechnology company committed to the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis, progressive...